有机硫化合物是指含有硫原子的有机化合物。这些化合物在自然界中广泛存在,在医药、农药和材料科学等领域有着重要的应用。有机硫化合物因其化学性质独特,在药物设计、合成化学以及材料制备方面扮演着重要角色。
1. 结构与分类有机硫化合物可以按硫的连接方式分为饱和和不饱和类,如二硫化物、噻吩衍生物、砜等。常见的结构类型有:
许多有机硫化合物在生物学上有重要功能或应用潜力。例如:
有机硫化合物可通过多种途径合成:
有机硫化合物的应用广泛:
尽管有机硫化合物具有许多潜在益处,但其生产和使用也可能对环境造成影响。因此,在设计和合成这些化合物时需要考虑可持续性和环保性因素。
以上是对有机硫化合物的简单介绍,包括它们的结构、生物学活性、合成方法及其应用领域等基本信息。
中文名称 | 英文名称 | CAS号 | 化学式 | 结构式图片 |
---|---|---|---|---|
—— | (2S)-2-[[5-(furan-2-yl)-1,3,4-oxadiazol-2-yl]sulfanyl]-N-[(4-methylphenyl)methyl]propanamide | —— | C17H17N3O3S |
|
—— | (2Z)-4-[[5-(furan-2-yl)-1,3,4-oxadiazol-2-yl]sulfanyl]-2-(2,5,6,7,8,9-hexahydro-[1,2,4]triazolo[4,3-a]azepin-3-ylidene)-3-oxobutanenitrile | —— | C17H16N6O3S |
|
—— | 2-(1-oxidopyridin-1-ium-2-yl)sulfanyl-1-(4-phenyl-3,6-dihydro-2H-pyridin-1-yl)ethanone | —— | C18H18N2O2S |
|
—— | (2R)-N-[(4-fluorophenyl)methyl]-2-[[5-(furan-2-yl)-1,3,4-oxadiazol-2-yl]sulfanyl]propanamide | —— | C16H14FN3O3S |
|
—— | N-[(2-fluorophenyl)methyl]-2-(1-oxidopyridin-1-ium-2-yl)sulfanylacetamide | —— | C14H13FN2O2S |
|
—— | (2S)-N-tert-butyl-2-[[5-(furan-2-yl)-1,3,4-oxadiazol-2-yl]sulfanyl]propanamide | —— | C13H17N3O3S |
|
—— | (2S)-2-[[5-(furan-2-yl)-1,3,4-oxadiazol-2-yl]sulfanyl]-N-propylpropanamide | —— | C12H15N3O3S |
|
—— | (2R)-2-[[5-(furan-2-yl)-1,3,4-oxadiazol-2-yl]sulfanyl]-N-(2-methylpropyl)propanamide | —— | C13H17N3O3S |
|
—— | (2R)-N-tert-butyl-2-[[5-(furan-2-yl)-1,3,4-oxadiazol-2-yl]sulfanyl]propanamide | —— | C13H17N3O3S |
|
—— | (2R)-N-cycloheptyl-2-[[5-(furan-2-yl)-1,3,4-oxadiazol-2-yl]sulfanyl]propanamide | —— | C16H21N3O3S |
|
—— | (2R)-N-[(3S)-1,1-dioxothiolan-3-yl]-2-[[5-(furan-2-yl)-1,3,4-oxadiazol-2-yl]sulfanyl]propanamide | —— | C13H15N3O5S2 |
|
—— | N-(6-amino-1-butyl-2,4-dioxopyrimidin-5-yl)-N-ethyl-2-(1-oxidopyridin-1-ium-2-yl)sulfanylacetamide | —— | C17H23N5O4S |
|
—— | N-[2-(4-bromophenyl)sulfanylethyl]-2-(1-oxidopyridin-1-ium-2-yl)sulfanylacetamide | —— | C15H15BrN2O2S2 |
|
—— | (2S)-2-[[5-(furan-2-yl)-1,3,4-oxadiazol-2-yl]sulfanyl]-N-(2-methoxyethyl)propanamide | —— | C12H15N3O4S |
|
—— | (2R)-2-[[5-(furan-2-yl)-1,3,4-oxadiazol-2-yl]sulfanyl]-N-(2-methoxyethyl)propanamide | —— | C12H15N3O4S |
|
—— | (2R)-N-(1-cyanocyclohexyl)-2-[[5-(furan-2-yl)-1,3,4-oxadiazol-2-yl]sulfanyl]-N-methylpropanamide | —— | C17H20N4O3S |
|
—— | (2S)-N-[(3R)-1,1-dioxothiolan-3-yl]-2-[[5-(furan-2-yl)-1,3,4-oxadiazol-2-yl]sulfanyl]propanamide | —— | C13H15N3O5S2 |
|
—— | N-[2-(3-chlorophenyl)ethyl]-2-(1-oxidopyridin-1-ium-2-yl)sulfanylacetamide | —— | C15H15ClN2O2S |
|
—— | N-[[5-(4-chlorophenyl)furan-2-yl]methyl]-N-methyl-2-(1-oxidopyridin-1-ium-2-yl)sulfanylacetamide | —— | C19H17ClN2O3S |
|
—— | N-[(2-methylphenyl)methyl]-2-(1-oxidopyridin-1-ium-2-yl)sulfanylacetamide | —— | C15H16N2O2S |
|
—— | (2S)-2-[[5-(furan-2-yl)-1,3,4-oxadiazol-2-yl]sulfanyl]-N-(thiophen-2-ylmethyl)propanamide | —— | C14H13N3O3S2 |
|
—— | (2S)-2-[[5-(furan-2-yl)-1,3,4-oxadiazol-2-yl]sulfanyl]-N-prop-2-enylpropanamide | —— | C12H13N3O3S |
|
—— | (2R)-N-[(3R)-1,1-dioxothiolan-3-yl]-2-[[5-(furan-2-yl)-1,3,4-oxadiazol-2-yl]sulfanyl]propanamide | —— | C13H15N3O5S2 |
|
—— | (2S)-N-(1-cyanocyclohexyl)-2-[[5-(furan-2-yl)-1,3,4-oxadiazol-2-yl]sulfanyl]-N-methylpropanamide | —— | C17H20N4O3S |
|
—— | (2R)-1-(azepan-1-yl)-2-[[5-(2-fluorophenyl)-1,3,4-oxadiazol-2-yl]sulfanyl]propan-1-one | —— | C17H20FN3O2S |
|
—— | (2S)-2-[[5-(2-fluorophenyl)-1,3,4-oxadiazol-2-yl]sulfanyl]-N-propylpropanamide | —— | C14H16FN3O2S |
|
—— | (2S)-N-(2-cyanoethyl)-2-[[5-(2-fluorophenyl)-1,3,4-oxadiazol-2-yl]sulfanyl]-N-methylpropanamide | —— | C15H15FN4O2S |
|
—— | (2S)-N-benzyl-N-tert-butyl-2-[[5-(2-fluorophenyl)-1,3,4-oxadiazol-2-yl]sulfanyl]propanamide | —— | C22H24FN3O2S |
|
—— | (2S)-N-cycloheptyl-2-[[5-(2-fluorophenyl)-1,3,4-oxadiazol-2-yl]sulfanyl]propanamide | —— | C18H22FN3O2S |
|
—— | (2S)-N-[(3S)-1,1-dioxothiolan-3-yl]-2-[[5-(2-fluorophenyl)-1,3,4-oxadiazol-2-yl]sulfanyl]-N-methylpropanamide | —— | C16H18FN3O4S2 |
|
—— | (2S)-N-[(3S)-1,1-dioxothiolan-3-yl]-N-ethyl-2-[[5-(2-fluorophenyl)-1,3,4-oxadiazol-2-yl]sulfanyl]propanamide | —— | C17H20FN3O4S2 |
|
—— | (2R)-N-(2-cyanoethyl)-2-[[5-(2-fluorophenyl)-1,3,4-oxadiazol-2-yl]sulfanyl]-N-methylpropanamide | —— | C15H15FN4O2S |
|
—— | 2-(2-Fluorophenyl)-5-[(3-thiophen-3-yl-1,2,4-oxadiazol-5-yl)methylsulfanyl]-1,3,4-oxadiazole | —— | C15H9FN4O2S2 |
|
—— | (2S)-N-[(3R)-1,1-dioxothiolan-3-yl]-2-[[5-(2-fluorophenyl)-1,3,4-oxadiazol-2-yl]sulfanyl]-N-methylpropanamide | —— | C16H18FN3O4S2 |
|
—— | (2R)-N-[(4-fluorophenyl)methyl]-2-[[5-(2-fluorophenyl)-1,3,4-oxadiazol-2-yl]sulfanyl]propanamide | —— | C18H15F2N3O2S |
|
—— | 2-[[5-(2-Fluorophenyl)-1,3,4-oxadiazol-2-yl]sulfanylmethyl]-7-methyl-[1,3,4]thiadiazolo[3,2-a]pyrimidin-5-one | —— | C15H10FN5O2S2 |
|
—— | (2R)-2-[[5-(2-fluorophenyl)-1,3,4-oxadiazol-2-yl]sulfanyl]-N-(2-methylpropyl)propanamide | —— | C15H18FN3O2S |
|
—— | (2R)-2-[[5-(2-fluorophenyl)-1,3,4-oxadiazol-2-yl]sulfanyl]-N-propylpropanamide | —— | C14H16FN3O2S |
|
—— | (2R)-2-[[5-(2-fluorophenyl)-1,3,4-oxadiazol-2-yl]sulfanyl]-N-prop-2-enylpropanamide | —— | C14H14FN3O2S |
|
—— | methyl N-[(2S)-2-[[5-(2-fluorophenyl)-1,3,4-oxadiazol-2-yl]sulfanyl]propanoyl]carbamate | —— | C13H12FN3O4S |
|
—— | (2E)-4-[[5-(2-fluorophenyl)-1,3,4-oxadiazol-2-yl]sulfanyl]-2-(2,5,6,7,8,9-hexahydro-[1,2,4]triazolo[4,3-a]azepin-3-ylidene)-3-oxobutanenitrile | —— | C19H17FN6O2S |
|
—— | (2S)-2-[[5-(2-fluorophenyl)-1,3,4-oxadiazol-2-yl]sulfanyl]-N-prop-2-enylpropanamide | —— | C14H14FN3O2S |
|
—— | (2S)-N-tert-butyl-2-[[5-(2-fluorophenyl)-1,3,4-oxadiazol-2-yl]sulfanyl]propanamide | —— | C15H18FN3O2S |
|
—— | (2R)-N-tert-butyl-2-[[5-(2-fluorophenyl)-1,3,4-oxadiazol-2-yl]sulfanyl]propanamide | —— | C15H18FN3O2S |
|
—— | (2S)-2-[[5-(2-fluorophenyl)-1,3,4-oxadiazol-2-yl]sulfanyl]-N-(2-methoxyethyl)propanamide | —— | C14H16FN3O3S |
|
—— | (2R)-N-[(3R)-1,1-dioxothiolan-3-yl]-2-[[5-(2-fluorophenyl)-1,3,4-oxadiazol-2-yl]sulfanyl]propanamide | —— | C15H16FN3O4S2 |
|
—— | (2S)-2-[[5-(2-fluorophenyl)-1,3,4-oxadiazol-2-yl]sulfanyl]-N-(2-methylpropyl)propanamide | —— | C15H18FN3O2S |
|
—— | (2R)-2-[[5-(2-fluorophenyl)-1,3,4-oxadiazol-2-yl]sulfanyl]-N-(2-methoxyethyl)propanamide | —— | C14H16FN3O3S |
|
—— | N-[[4-(dimethylamino)phenyl]methyl]-2-(2,4-dimethylphenyl)sulfanylacetamide | —— | C19H24N2OS |
|
—— | 1-methyl-1-[(1-methylpiperidin-4-yl)methyl]-3-[(2S)-2-phenylsulfanylpropyl]urea | —— | C18H29N3OS |
|